Novel approaches to thrombolysis based on modulation of endogenous fibrinolysis

Coron Artery Dis. 1998;9(2-3):99-104.

Authors

S Stefansson¹, D A Lawrence, T Herren, E F Plow

Affiliation

¹ American Red Cross, Holland Laboratory, Department of Biochemistry, Rockville, Maryland, USA.

PMID: 9647410

No abstract available

Publication types

Review

MeSH terms

Animals
Carboxypeptidase B
Carboxypeptidases / metabolism*
Cardiovascular Diseases / drug therapy
Cardiovascular Diseases / enzymology*
Factor XIII / metabolism*
Factor XIII / therapeutic use
Fibrinolysis / drug effects
Fibrinolysis / physiology*
Humans
Plasminogen Activator Inhibitor 1 / metabolism*
Plasminogen Activator Inhibitor 1 / therapeutic use
Serine Proteinase Inhibitors / metabolism*
Serine Proteinase Inhibitors / therapeutic use
Thrombolytic Therapy

Substances

Plasminogen Activator Inhibitor 1
Serine Proteinase Inhibitors
Factor XIII
Carboxypeptidases
Carboxypeptidase B